TAS2R60
gene geneOn this page
Also known as T2R60
Summary
TAS2R60 (taste 2 receptor member 60, HGNC:20639) is a protein-coding gene on chromosome 7q35, encoding Taste receptor type 2 member 60 (P59551). Receptor that may play a role in the perception of bitterness and is gustducin-linked.
This gene encodes a member of the bitter taste receptor family which belong to the G protein-coupled receptor superfamily and are predominantly expressed in taste receptor cells of the tongue and palate epithelia. This intronless taste receptor gene encodes a seven-transmembrane receptor protein, functioning as a bitter taste receptor. This gene is clustered together with eight other taste receptor genes on chromosome 7.
Source: NCBI Gene 338398 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total — 1 pathogenic
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_177437
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20639 |
| Approved symbol | TAS2R60 |
| Name | taste 2 receptor member 60 |
| Location | 7q35 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | T2R60 |
| Ensembl gene | ENSG00000185899 |
| Ensembl biotype | protein_coding |
| OMIM | 613968 |
| Entrez | 338398 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000332690
RefSeq mRNA: 1 — MANE Select: NM_177437
NM_177437
CCDS: CCDS5885
Canonical transcript exons
ENST00000332690 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001317227 | 143443453 | 143444409 |
Expression profiles
Bgee: expression breadth broad, 17 present calls, max score 55.76.
Top tissues by expression
98 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 55.76 | gold quality |
| colonic epithelium | UBERON:0000397 | 55.47 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 50.74 | gold quality |
| bone marrow cell | CL:0002092 | 49.08 | gold quality |
| blood | UBERON:0000178 | 45.23 | gold quality |
| leukocyte | CL:0000738 | 43.39 | gold quality |
| sural nerve | UBERON:0015488 | 43.38 | gold quality |
| monocyte | CL:0000576 | 42.71 | gold quality |
| vermiform appendix | UBERON:0001154 | 40.37 | silver quality |
| granulocyte | CL:0000094 | 37.86 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.58 | gold quality |
| liver | UBERON:0002107 | 36.55 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| placenta | UBERON:0001987 | 36.30 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| tonsil | UBERON:0002372 | 34.66 | gold quality |
| urinary bladder | UBERON:0001255 | 34.03 | silver quality |
| muscle tissue | UBERON:0002385 | 33.41 | gold quality |
| lymph node | UBERON:0000029 | 33.34 | silver quality |
| right lobe of liver | UBERON:0001114 | 33.15 | silver quality |
| skin of leg | UBERON:0001511 | 33.09 | gold quality |
| left uterine tube | UBERON:0001303 | 31.88 | silver quality |
| rectum | UBERON:0001052 | 31.77 | gold quality |
| right uterine tube | UBERON:0001302 | 30.93 | gold quality |
| zone of skin | UBERON:0000014 | 30.77 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| fundus of stomach | UBERON:0001160 | 29.57 | silver quality |
| calcaneal tendon | UBERON:0003701 | 29.43 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.40 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.38 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tas2r200.2 | ENSDARG00000074066 |
| danio_rerio | tas2r200.1 | ENSDARG00000079880 |
| mus_musculus | Tas2r135 | ENSMUSG00000056203 |
| rattus_norvegicus | Tas2r135 | ENSRNOG00000026811 |
Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)
Protein
Protein identifiers
Taste receptor type 2 member 60 — P59551 (reviewed: P59551)
Alternative names: Taste receptor type 2 member 56
All UniProt accessions (1): P59551
UniProt curated annotations — full annotation on UniProt →
Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5.
Subcellular location. Membrane.
Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells.
Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.
Similarity. Belongs to the G-protein coupled receptor T2R family.
RefSeq proteins (1): NP_803186* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007960 | TAS2R | Family |
Pfam: PF05296
UniProt features (17 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59551-F1 | 78.02 | 0.20 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 179
Function
Pathways and Gene Ontology
Reactome pathways
6 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
MSigDB gene sets: 26 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr7q35, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOBP_DETECTION_OF_CHEMICAL_STIMULUS
GO Biological Process (4): sensory perception of bitter taste (GO:0050913), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), bitter taste receptor activity (GO:0033038)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-4 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| GPCR downstream signalling | 1 |
| GPCR ligand binding | 1 |
| Signal Transduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| sensory perception of taste | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of bitter taste | 1 |
| taste receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
418 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAS2R60 | PKD2L1 | Q9P0L9 | 590 |
| TAS2R60 | OR2M4 | Q96R27 | 575 |
| TAS2R60 | PKD1L3 | Q7Z443 | 573 |
| TAS2R60 | TAS1R1 | Q7RTX1 | 532 |
| TAS2R60 | TAS1R2 | Q8TE23 | 532 |
| TAS2R60 | TAS2R50 | P59544 | 514 |
| TAS2R60 | OR8H1 | Q8NGG4 | 506 |
| TAS2R60 | GPRC6A | Q5T6X5 | 504 |
| TAS2R60 | TAS1R3 | Q7RTX0 | 481 |
| TAS2R60 | SCNN1D | P51172 | 480 |
| TAS2R60 | OR5K2 | Q8NHB8 | 470 |
| TAS2R60 | OR6N1 | Q8NGY5 | 448 |
| TAS2R60 | GNAT3 | A8MTJ3 | 447 |
| TAS2R60 | OR7D4 | Q8NG98 | 447 |
| TAS2R60 | OR13F1 | Q8NGS4 | 439 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TAS2R60 | LRRK2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TAS2R60 | DAPK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TAS2R60 | MFHAS1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (4): TAS2R60 (Reconstituted Complex), TAS2R60 (Reconstituted Complex), TAS2R60 (Reconstituted Complex), TAS2R60 (Negative Genetic)
ESM2 similar proteins: A0A0R4IM31, A0A0R4IP11, P59532, P59533, P59536, P59551, Q2AB83, Q4VHE7, Q5J3F6, Q5J3L4, Q5J3L7, Q5J3M3, Q5J3M9, Q5J3N1, Q5Y4Z0, Q645S2, Q645U0, Q645U6, Q645U7, Q645Y3, Q645Z0, Q645Z1, Q646A4, Q646A5, Q646B2, Q646C7, Q646D0, Q646D5, Q646E6, Q646E9, Q646F3, Q67ER9, Q67ES2, Q67ES7, Q697L2, Q697L3, Q697L4, Q697L5, Q697L6, Q7TQA6
Diamond homologs: P59529, P59536, P59551, Q5Y4Z0, Q645S2, Q645U1, Q645U2, Q645U6, Q645U7, Q645Y3, Q645Y4, Q645Z0, Q646A5, Q646B2, Q646B3, Q646C7, Q646D0, Q646D1, Q646E7, Q646E8, Q646F1, Q646F3, Q646G6, Q67ES2, Q67ES3, Q67ES7, Q7M720, Q7TQA7, Q7TQA9, Q7TQB0, Q7TQB9, Q9JKE7, Q9JKF0, Q9JKT7, Q9JKU0, Q9NYV7, P59530, P59532, P59534, P59537
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 144163 | GRCh38/hg38 7q34-35(chr7:141126407-145652221)x3 | Pathogenic |
SpliceAI
245 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:143443541:T:TA | donor_gain | 0.9100 |
| 7:143443542:A:AA | donor_gain | 0.9100 |
| 7:143443554:C:T | donor_gain | 0.9000 |
| 7:143444090:T:G | acceptor_gain | 0.8200 |
| 7:143443497:G:GT | donor_gain | 0.8000 |
| 7:143443619:A:G | donor_gain | 0.8000 |
| 7:143444089:AT:A | acceptor_gain | 0.7900 |
| 7:143443672:ATGG:A | donor_gain | 0.7500 |
| 7:143444089:A:AG | acceptor_gain | 0.7400 |
| 7:143443556:A:AG | donor_gain | 0.7300 |
| 7:143443490:C:G | donor_gain | 0.7200 |
| 7:143444346:CAGCA:C | acceptor_gain | 0.6900 |
| 7:143444347:AGCAA:A | acceptor_gain | 0.6900 |
| 7:143443594:C:CG | donor_gain | 0.6800 |
| 7:143444345:TCAG:T | acceptor_gain | 0.6700 |
| 7:143443935:A:AG | acceptor_gain | 0.6600 |
| 7:143443936:G:GG | acceptor_gain | 0.6600 |
| 7:143444288:G:A | acceptor_gain | 0.6500 |
| 7:143443587:G:GG | donor_gain | 0.6300 |
| 7:143443586:A:AG | donor_gain | 0.6200 |
| 7:143443931:TCATA:T | acceptor_loss | 0.6200 |
| 7:143443935:AGG:A | acceptor_loss | 0.6200 |
| 7:143443936:G:GT | acceptor_loss | 0.6200 |
| 7:143444344:TTCAG:T | acceptor_gain | 0.6100 |
| 7:143444348:G:T | acceptor_gain | 0.6100 |
| 7:143444348:GC:G | acceptor_gain | 0.6000 |
| 7:143444348:GCA:G | acceptor_gain | 0.6000 |
| 7:143444347:A:AG | acceptor_gain | 0.5900 |
| 7:143444348:G:GG | acceptor_gain | 0.5900 |
| 7:143444348:GCAA:G | acceptor_gain | 0.5800 |
AlphaMissense
2073 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:143443909:A:C | S153R | 0.839 |
| 7:143443911:C:A | S153R | 0.839 |
| 7:143443911:C:G | S153R | 0.839 |
| 7:143444077:T:C | F209L | 0.835 |
| 7:143444079:T:A | F209L | 0.835 |
| 7:143444079:T:G | F209L | 0.835 |
| 7:143444206:T:C | F252L | 0.789 |
| 7:143444208:T:A | F252L | 0.789 |
| 7:143444208:T:G | F252L | 0.789 |
| 7:143444218:T:C | F256L | 0.779 |
| 7:143444220:C:A | F256L | 0.779 |
| 7:143444220:C:G | F256L | 0.779 |
| 7:143443756:T:C | F102L | 0.770 |
| 7:143443758:C:A | F102L | 0.770 |
| 7:143443758:C:G | F102L | 0.770 |
| 7:143443711:T:C | F87L | 0.765 |
| 7:143443713:C:A | F87L | 0.765 |
| 7:143443713:C:G | F87L | 0.765 |
| 7:143443840:T:C | F130L | 0.760 |
| 7:143443842:C:A | F130L | 0.760 |
| 7:143443842:C:G | F130L | 0.760 |
| 7:143443795:A:C | S115R | 0.745 |
| 7:143443797:T:A | S115R | 0.745 |
| 7:143443797:T:G | S115R | 0.745 |
| 7:143443633:A:C | S61R | 0.738 |
| 7:143443635:C:A | S61R | 0.738 |
| 7:143443635:C:G | S61R | 0.738 |
| 7:143443801:T:C | F117L | 0.729 |
| 7:143443803:C:A | F117L | 0.729 |
| 7:143443803:C:G | F117L | 0.729 |
dbSNP variants (sampled 300 via entrez): RS1000747422 (7:143444041 C>T), RS1004448451 (7:143441974 T>G), RS1004903987 (7:143441703 T>A), RS1005203496 (7:143444711 A>G), RS1005501402 (7:143442961 G>A,C,T), RS1005863557 (7:143443074 A>G), RS1006681966 (7:143443140 C>A), RS1006698533 (7:143443949 T>C,G), RS1008641040 (7:143442731 C>T), RS1009436705 (7:143444730 G>A), RS1009852333 (7:143444666 C>A), RS1010977899 (7:143442355 A>G), RS1011468654 (7:143442660 T>A), RS1012637026 (7:143442955 C>A), RS1013213242 (7:143444338 C>T)
Disease associations
OMIM: gene MIM:613968 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL3309109 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL434 | ISOPROTERENOL | 4 | 40,234 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Taste 2 receptors
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.31 | EC50 | 4.9 | nM | ISOPROTERENOL |
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Aldehydes | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Endosulfan | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
ChEMBL screening assays
5 unique, capped per target: 4 functional, 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL3361958 | Binding | Agonist activity at human TAS2R60 expressed in U2OS cells by Ga16gust44 Clone 7A FLIPR/summary (Abse5) assay | Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). — Bioorg Med Chem Lett |
| CHEMBL4419025 | Functional | Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R60 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay | Methods of identifying antagonists of the hTAS2R46 bitter taste receptor |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.